Development of Reservoir Vaginal Rings Containing Dapivirine or Hormonal Contraceptive Steroids
McCoy, C; Boyd, P; Fetherston, S; Major, I; Murphy, D; Brimer, A; Holt, J; Devlin, B; Blanda, W; Derrick, T; Gimour, C; Nuttall, J; Malcolm, K
Aids Research and Human Retroviruses 30(S1): A68-A68
2014
ISSN/ISBN: 0889-2229 DOI: 10.1089/aid.2014.5124.abstractDocument Number: 449721
Document emailed within 0-6 h
Related Documents
Boyd, P.; Fetherston, S.M.; McCoy, C.F.; Major, I.; Murphy, D.J.; Kumar, S.; Holt, J.; Brimer, A.; Blanda, W.; Devlin, B.; Malcolm, R.K. 2016: Matrix and reservoir-type multipurpose vaginal rings for controlled release of dapivirine and levonorgestrel International Journal of Pharmaceutics 511(1): 619-629Konstantinus, I.N.; Balle, C.; Jaumdally, S.Z.; Galmieldien, H.; Pidwell, T.; Masson, L.; Tanko, R.F.; Happel, A.-U.; Sinkala, M.; Myer, L.; Bosinger, S.E.; Gill, K.; Bekker, L.-G.; Jaspan, H.B.; Passmore, J.-A.S. 2020: Impact of Hormonal Contraceptives on Cervical T-helper 17 Phenotype and Function in Adolescents: Results from a Randomized, Crossover Study Comparing Long-acting Injectable Norethisterone Oenanthate (NET-EN), Combined Oral Contraceptive Pills, and Combined Contraceptive Vaginal Rings Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 71(7): E76-E87
Jensen, J.T.; Archer, D.F.; Westhoff, C.L.; Nelson, A.L.; Graham, S.; Bernick, B. 2023: Satisfaction with a Segesterone Acetate and Ethinyl Estradiol Contraceptive Vaginal System Among Recent Oral Contraceptive or Hormonal Contraceptive Vaginal Ring Users Journal of Women's Health 32(7): 808-815
Devlin, Bíd.; Nuttall, J.; Wilder, S.; Woodsong, C.; Rosenberg, Z. 2013: Development of dapivirine vaginal ring for HIV prevention Antiviral Research 100 Suppl: S3-S8
Murphy, D.J.; Desjardins, D.; Dereuddre-Bosquet, N.; Brochard, P.; Perrot, L.; Pruvost, A.; Le Grand, R.; Lagatie, O.; Vanhooren, L.; Feyaerts, M.; van Roey, J.; Malcolm, R.K. 2014: Pre-clinical development of a combination microbicide vaginal ring containing dapivirine and darunavir Journal of Antimicrobial ChemoTherapy 69(9): 2477-2488
Harwood, B.; Mishell, D.R. 2001: Contraceptive vaginal rings Seminars in Reproductive Medicine 19(4): 381-390
Mishell, D.R. 1993: Vaginal contraceptive rings Annals of Medicine 25(2): 191-197
Harwood, B.; Mishell, D.R. 2001: Contraceptive vaginal rings Seminars in Reproductive Medicine 19(4): 381-390
Brache, V.; Faundes, A. 2010: Contraceptive vaginal rings: a review Contraception 82(5): 418-427
Brache, V.; Faundes, A. 2010: Contraceptive vaginal rings: a review Contraception 82(5): 418-427
Jackson, R.; Hickling, D.; Assendorp, R.; Elstein, M. 1990: Present status of contraceptive vaginal rings Advances in Contraception: the Official Journal of the Society for the Advancement of Contraception 6(3): 169-176
Serati, M.; Bogani, G.; Di Dedda, M.C.; Braghiroli, A.; Uccella, S.; Cromi, A.; Ghezzi, F. 2015: A comparison between vaginal estrogen and vaginal hyaluronic for the treatment of dyspareunia in women using hormonal contraceptive European Journal of Obstetrics Gynecology and Reproductive Biology 191: 48-50
Paresi, R.J.; Myers, R.S.; Matarasso, A. 2015: Contraceptive Vaginal Rings: do they Pose an Increased Risk of Venous Thromboembolism in Aesthetic Surgery? Aesthetic Surgery Journal 35(6): 721-727
Paresi, R.J.; Myers, R.S.; Matarasso, A. 2015: Contraceptive Vaginal Rings: do they Pose an Increased Risk of Venous Thromboembolism in Aesthetic Surgery? Aesthetic Surgery Journal 35(6): 721-727
Sivin, I.; Mishell, D.R.; Alvarez, F.; Brache, V.; Elomaa, K.; Lähteenmäki, P.; Massai, R.; Miranda, P.; Croxatto, H.; Dean, C.; Small, M.; Nash, H.; Jackanicz, T.M. 2005: Contraceptive vaginal rings releasing Nestorone and ethinylestradiol: a 1-year dose-finding trial Contraception 71(2): 122-129
Mehta, S.; Joshi, U.M.; Sankolli, G.M.; Adatia, A.; Donde, U.M.; Saxena, B.N. 1981: Clinical performance and endocrine profiles with contraceptive vaginal rings containing a combination of estradiol and D-norgestrel Contraception 23(3): 241-250
Singh, B.; Cutler, J.C.; Utidjian, H.M. 1972: Studies on the development of a vaginal preparation providing both prophylaxis against venereal disease and other genital infections and contraception. II. Effect in vitro of vaginal contraceptive and non-contraceptive preparations on Treponema pallidum and Neisseria gonorrhoeae British Journal of Venereal Diseases 48(1): 57-64
Ahrén, T.; Victor, A.; Lithell, H.; Vessby, B.; Jackanicz, T.M.; Johansson, E.D. 1983: Ovarian function, bleeding control and serum lipoproteins in women using contraceptive vaginal rings releasing five different progestins Contraception 28(4): 315-327
Boyd, P.; Major, I.; Wang, W.; McConville, C. 2014: Development of disulfiram-loaded vaginal rings for the localised treatment of cervical cancer European Journal of Pharmaceutics and Biopharmaceutics: Official Journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik E.V 88(3): 945-953
Mc Conville, C.; Major, I.; Friend, D.R.; Clark, M.R.; Woolfson, A.D.; Malcolm, R.K. 2012: Development of polylactide and polyethylene vinyl acetate blends for the manufacture of vaginal rings Journal of Biomedical Materials Research. Part B Applied Biomaterials 100(4): 891-895